CP
Catalyst Pharmaceuticals Inc
🇩🇪XFRA.CN2GermanyHealthcare
€27.30EURunchanged 0.00 (0%)OpenEnd of day6:03 PM
Price€27.300.00 (0%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US14888U1016
- CUSIP
- Not reported
Company
- Employees
- 182
- Headquarters
- Coral Gables, United States
- Website
- https://catalystpharma.com
- CEO
- Mr. Richard John Daly M.B.A.
Market
- Shares outstanding
- 122.9M
- Market cap
- €3.36B
Highlights
No high and low reported for today's session.
- Market cap
- €3.36B
- EPS LTM
- $1.74
- P/E LTM
- 14.21
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $596.96M+11.65%up year on year
- Net income
- $221.32M+12.15%up year on year
- Gross margin
- 82.32%-4.4%down year on year
- Free cash flow
- $208.13M-22.21%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.